Health

  • March 12, 2026

    Wash. Justices OK Jury Instruction In TB Malpractice Case

    The Washington State Supreme Court declined Thursday to flip a family's loss in a case blaming an Evergreen State doctor for failing to address signs of an intestinal tuberculosis infection that led to a patient's death, rejecting a challenge to a jury instruction on the physician's exercise of judgment.

  • March 12, 2026

    Colo. Panel Clarifies Workers Comp Law On Maintenance Care

    In interpreting the Colorado Workers' Compensation Act, the Colorado Court of Appeals ruled for the first time Thursday that employers and their insurers cannot limit maintenance medical benefits to any specific treatment in a final admission of liability.

  • March 12, 2026

    Insurer Asks NC Justices To Free It From Captive Carrier Row

    A Georgia insurance company told North Carolina's highest court that the state's Business Court doesn't have jurisdiction over it in a shareholder dispute over the demise of a defunct captive insurer, arguing it had nothing to do with the supposed bad acts of its individual members.

  • March 12, 2026

    Embryo Loss Suits Need 'Serious' Edits, Judge Told

    Two complaints against fertility products maker CooperSurgical Inc. require "serious" amendments to clarify the nature of the claims that a defective culture medium caused embryo losses for in vitro fertilization patients, the company told a Connecticut federal judge Thursday.

  • March 12, 2026

    Meta To Face Sanctions Bid Over Addiction MDL Privilege Log

    School district plaintiffs and attorneys general have told a California federal judge they plan to seek sanctions against Meta Platforms Inc. in the social media addiction multidistrict litigation for the tech giant's "extremely belated production" of over 73,841 documents downgraded off privilege logs, months after fact discovery closed.

  • March 12, 2026

    US Chamber Report Warns Of Risks To IP Protection

    While the U.S. has ranked at the top of the U.S. Chamber of Commerce's list measuring how countries worldwide are enforcing intellectual property laws, the group said problems with free trade agreements and efforts to reduce pharmaceutical prices could cause problems on the horizon domestically.

  • March 12, 2026

    Idaho Says Director Immune In THC Child Abuse Registry Suit

    The director of Idaho Health and Welfare is asking a federal court to throw out claims from two women alleging the state violated their constitutional rights by putting them on the state's child abuse registry for their use of cannabis while pregnant, saying the director is immune and the state's rules satisfy due process.

  • March 12, 2026

    NFL Alumni Argues Biotech's Suit Lacks Contractual Basis

    The National Football League's largest alumni group is angling to quash a biotech company's breach of contract lawsuit, explaining that details in the suit on the termination of their partnership for a vaccine education program are thin.

  • March 12, 2026

    Doc's Hands Aren't Property, Texas Panel Rules In Death Suit

    A state-employed doctor's hands are not "tangible personal property," a Texas appeals court ruled Thursday, dismissing a wrongful death suit from the family of a patient who contracted a fatal infection during her hospital stay. 

  • March 11, 2026

    DNA Testing Co. Can't Shake Suit Over Genetic Data Sharing

    A Massachusetts federal judge refused to release Nebula Genomics Inc. from a proposed class action accusing it of illegally sharing its customers' genetic information with Meta and other third parties through online tracking tools, finding that the parties' choice-of-law agreement didn't extend to the plaintiff's genetic privacy allegation. 

  • March 11, 2026

    Eli Lilly Ordered To Arbitrate Alzheimer's Drug Feud

    An Illinois federal judge ordered Eli Lilly and Co. on Tuesday to arbitrate a dispute over millions of dollars in milestone payments allegedly owed under a collaboration agreement to develop an Alzheimer's disease drug, ruling that the drugmaker lacked standing to challenge an underlying security agreement.

  • March 11, 2026

    New Wyoming Abortion Law Faces Familiar Legal Challenge

    Just a day after it was signed into law, Wyoming's new anti-abortion law triggered a legal challenge from the same health clinic that successfully sued over the state's previous abortion limits.

  • March 11, 2026

    La. Fights Dismissal Bid In Abortion Regulation Dispute

    The state of Louisiana urged a federal court to deny motions by GenBioPro Inc. and Danco Laboratories seeking dismissal of its suit challenging federal regulation on mail-order abortion drugs, arguing it has established harms stemming from the regulations.

  • March 11, 2026

    Ohio Hospital Defeats DaVita's Dialysis Discrimination Suit

    An Ohio hospital and its health benefit plan did not discriminate against patients with end-stage renal disease by eliminating in-network coverage for dialysis, a federal court ruled, finding that dialysis provider DaVita Inc. failed to show the plan intended to harm participants.

  • March 11, 2026

    Wash. Says ICE Contractor Cannot Defend Barring Inspection

    The Washington State Department of Health said a contractor's attempts to escape an evidentiary hearing demonstrated that the company could not defend its jurisdictional claims in a lawsuit accusing it of illegally restricting access to an immigration facility.

  • March 11, 2026

    Allstate Says Chiropractors Ran 'Personal Injury Mill'

    Allstate told a Texas federal court in a lawsuit seeking at least $25.8 million that two chiropractors and their associated healthcare entities operated a racketeering enterprise to make money from automobile accident personal injury settlements.

  • March 11, 2026

    Insulin Makers Ask Justices To Review Collusion Case

    Sanofi-Aventis US, Eli Lilly & Co., Novo Nordisk Inc. and AstraZeneca Pharmaceuticals LP have told the U.S. Supreme Court that a ruling reviving a case over insulin drug costs undermines key rules meant to weed out improper antitrust claims.

  • March 11, 2026

    Pharma Co. Says Ex-Director Using Trade Secrets At New Job

    A specialty infusion therapy pharmacy has accused a former director of contracts of taking valuable trade secrets with her on her way out to work for a rival company.

  • March 11, 2026

    VA, DOJ Cut Deal To Make Attys Mental Health Guardians

    Under a new initiative, attorneys at the U.S. Department of Justice will serve as legal guardians for some homeless veterans, the Trump administration announced on Wednesday, though some veterans advocates expressed concern that the new program could involuntarily coerce veterans experiencing mental health issues into institutional care.

  • March 11, 2026

    Pa. Justices Hint 3rd Jury Should Decide Misdiagnosis Case 

    The Pennsylvania Supreme Court on Wednesday appeared skeptical of an oncologist's argument that she should not have to face a third trial in a suit accusing her of treating a now-deceased woman for the wrong type of cancer, suggesting that disputed facts about the patient's care make the case suitable for a jury.

  • March 11, 2026

    Pa. Justices Doubtful Law Unclear In AG-DA Opioid Deal Row

    Multiple Pennsylvania Supreme Court justices on Wednesday doubted a state law was ambiguous about whether the attorney general could step in and settle claims brought by county-level district attorneys, as he had in a multistate settlement with opioid companies.

  • March 11, 2026

    Minn. Lawmakers Advance Medical Psilocybin Bill

    Minnesota lawmakers this week advanced a bipartisan bill to create a regulated medical program for psilocybin, the active ingredient in psychoactive mushrooms.

  • March 11, 2026

    SEC Avoids Sanctions As Court Ends Unregistered Dealer Suit

    A Minnesota federal judge denied financial firm Carebourn Capital's request for sanctions against the U.S. Securities and Exchange Commission and dismissed the agency's suit, which claims that Carebourn, its founder and an affiliated company made millions by selling securities as unregistered dealers.

  • March 11, 2026

    Union Claims NJ Hospital Broke State Law In Layoffs

    An American Federation of State, County and Municipal Employees local has accused a New Jersey hospital of violating state law by abruptly closing most of its facility in November without giving proper notice, in a complaint in New Jersey state court.

  • March 11, 2026

    Biomedical Co. Settles Trade Secrets Case Against Ex-Worker

    Biomedical company Skye Orthobiologics and a former employee have informed a California federal judge that they have settled a case accusing the ex-employee of breaching fiduciary duties by leveraging Skye's proprietary information.

Expert Analysis

  • Series

    Law School's Missed Lessons: Practical Problem Solving

    Author Photo

    Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.

  • Intellectual Property Challenges In AI-Driven Drug Discovery

    Author Photo

    Given the adoption of artificial intelligence-based drug discovery platforms and the U.S. Patent and Trademark Office's recent guidance on determining inventorship in AI-assisted inventions, practitioners must consider unprecedented questions regarding inventorship, patentability standards and infringement liability, says Paul Calvo at Sterne Kessler.

  • Learning From 2025 FCA Trends Targeting PE In Healthcare

    Author Photo

    False Claims Act enforcement trends and legislative developments from this year signal intensifying state and federal scrutiny of private equity's growing footprint in healthcare, and the urgency of compliance, says Lisa Re at Arnold & Porter.

  • Opinion

    A Uniform Federal Rule Would Curb Gen AI Missteps In Court

    Author Photo

    To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.

  • Riding The Changing Winds For AI Innovations At The USPTO

    Author Photo

    As recent U.S. Patent and Trademark Office moves reshape how artificial intelligence inventions will be examined and put them on firmer eligibility footing, practitioners need to consider how this shift is both an opportunity and a challenge, say Ryan Phelan at Marshall Gerstein and attorney Mark Campagna.

  • Series

    The Law Firm Merger Diaries: Integrating Practice Groups

    Author Photo

    Enacting unified leadership and consistent client service standards ensures law firm practice groups connect and collaborate around shared goals, turning a law firm merger into a platform for growth rather than a period of disruption, says Brian Catlett at Fennemore Craig.

  • Nonprofits Face Uncertainty Over Political Activity Rules

    Author Photo

    Two federal court decisions suggesting that the Internal Revenue Service's rules for 501(c)(4) organizations' political activity may be too vague to survive constitutional scrutiny leave nonprofit organizations caught between constitutional limits on government regulation of speech and tax limits on their exempt status, say attorneys at BakerHostetler.

  • Opinion

    Supreme Court Term Limits Would Carry Hidden Risk

    Author Photo

    While proposals for limiting the terms of U.S. Supreme Court justices are popular, a steady stream of relatively young, highly marketable ex-justices with unique knowledge and influence entering the marketplace of law and politics could create new problems, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.

  • Next Steps For Orgs. Amid Updated OpenAI Usage Policies

    Author Photo

    OpenAI's updates to its usage policies, clarifying that its tools are not substitutes for professional medical, legal or other regulated advice, sends a clear signal that organizations should mirror this clarity in their governance policies to mitigate compliance and liability exposure, say attorneys at Baker Donelson.

  • Series

    Knitting Makes Me A Better Lawyer

    Author Photo

    Stretching my skills as a knitter makes me a better antitrust attorney by challenging me to recalibrate after wrong turns, not rush outcomes, and trust that I can teach myself the skills to tackle new and difficult projects — even when I don’t have a pattern to work from, says Kara Kuritz at V&E.

  • How 11th Circ.'s Qui Tam Review Could Affect FCA Litigation

    Author Photo

    On Dec. 12, the Eleventh Circuit will hear arguments in U.S. ex rel. Zafirov v. Florida Medical Associates, setting the stage for a decision that could drastically reduce enforcement under the False Claims Act, and presenting an opportunity to seek U.S. Supreme Court review of the act's whistleblower provisions, say attorneys at Epstein Becker.

  • Series

    The Biz Court Digest: Welcome To Miami

    Author Photo

    After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.

  • How MAHA Is Taking Shape At The State Level

    Author Photo

    The national spotlight on the federal government's Make America Healthy Again movement is bolstering state-level actions regarding potential health impacts of certain food ingredients, increasing the difficulty and importance of maintaining effective compliance programs, say attorneys at Cooley.

  • AI Evidence Rule Tweaks Encourage Judicial Guardrails

    Author Photo

    Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.

  • Series

    The Law Firm Merger Diaries: Getting The Message Across

    Author Photo

    Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.